Biological E, the second biggest vaccine maker after Bharat Biotech from Hyderabad, has successfully completed the phase-2 and phase-3 clinical trials on its Corbevax Covid vaccine, which is being developed by the firm in collaboration with Baylor College of Medicine, Houston, Texas and Dynavax from California. According to Mahima Datla, chairman and managing director of Biological E, the phase-2 and phase-3 clinical trials have already been successfully completed recently and the same will be submitted to the DCGI for getting emergency usage authorization (EUA).
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!